Algorithm-based assessment of T-cell dysfunction and exclusion to forecast ICB sensitivity in pediatric brain ependymoma
Matteo Palermo, Luca Massimi, Giampiero Tamburrini, Alessandro Olivi, Francesco Doglietto, Alessio Albanese, Carmelo Lucio Sturiale · 2025
Read Algorithm-based assessment of T-cell dysfunction and exclusion to forecast ICB sensitivity in pediatric brain ependymoma by Matteo Palermo, Luca Massimi, Giampiero Tamburrini, Alessandro Olivi, Francesco Doglietto, Alessio Albanese, Carmelo Lucio Sturiale (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12717181.txt.
Description
Matteo Palermo and co-authors test in 2025 whether a scoring algorithm can forecast which childhood brain tumors might answer immune therapy. Ependymomas are hard to cure even with surgery and radiation, and checkpoint immunotherapy usually fails in such cold tumors, where immune cells barely enter. A tool called TIDE scores a tumor's immune dysfunction and exclusion from its gene activity, estimating the odds of response.
The team ran TIDE on gene data from four public sets, covering well over a hundred young patients' tumors across the known molecular subgroups. Six in ten tumors were predicted responders, a surprisingly hopeful share. One fusion defined subgroup scored far better than the largest subgroup, with less T cell dysfunction. Tumors that had come back after treatment also scored better than first time ones. The authors suggest some ependymomas, against reputation, may be worth a checkpoint trial.
Catalog record
| CREATOR | Matteo Palermo, Luca Massimi, Giampiero Tamburrini, Alessandro Olivi, Francesco Doglietto, Alessio Albanese, Carmelo Lucio Sturiale |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |